Both in Biotechnology
Tevogen vs Neumora Therapeutics
Over the past year TVGN returned −78.8% and NMRA returned −81.4%; their daily moves had a correlation of 0.00.
TVGN −78.8% NMRA −81.4%Growth of $1, one year, split-adjusted
| Metric | TVGN | NMRA |
|---|---|---|
| Price | $5.56 | $0.4870 |
| Market cap | $93.2M | $91.5M |
| Today | −2.80% | −13.96% |
| 1 month | −14.3% | +4.0% |
| 6 months | −25.7% | −74.9% |
| Year to date | −66.4% | −72.8% |
| 1 year | — | −82.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$7.0M | $63.9M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 128.3% |
| Short % of float | 3.9% | 6.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).